The overall incidence of esophageal secondary malignancies is low in patients with HNSCC
Are Neuromodulating Medications Effective for Treatment of Chronic Neurogenic Cough?
The use of neuromodulators appears to be helpful in patients with chronic idiopathic/ neurogenic cough
Should Surgeons Routinely Inform Patients about Risks of Taste Dysfunction after Tongue Base Surgery for Sleep Apnea?
The incidence of alteration in taste sensation with coblation lingual tonsillectomy, TORS tongue-base reduction, and submucosal lingualplasty is sufficiently high to warrant warning patients.
When Should Surveillance Imaging Be Performed After Treatment for Head and Neck Cancer?
The majority of recurrences occur within the first two posttreatment years
Is Laryngeal Framework Surgery Safe in the Radiated Larynx?
TRIO Best Practice articles are brief, structured reviews designed to provide the busy clinician with a handy outline and reference for day-to-day clinical decision making. The ENTtoday summaries below include the Background and Best Practice sections of the original article. To view the complete Laryngoscope articles free of charge, visit Laryngoscope. Background Medialization procedures reliably […]
Is Aspirin Desensitization Indicated for Treatment of Recalcitrant CRSwNP in AERD?
Desensitization is cost-effective, with several high-quality studies demonstrating improved disease control
Should Adult Surgical Tracheostomies Include a Bjork Flap?
Available evidence suggests the clear safety of the bjork flap, but there is not enough of it to recommend it at this time
Can Topical Beta-Blockers Reduce the Size of Superficial Infantile Hemangiomas of the Head and Neck?
Topical beta-blocker therapy is a safe treatment for patients that meet a certain criteria
Is Bevacizumab Effective for Reducing Epistaxis in Hereditary Hemorrhagic Telangiectasia?
Hereditary hemorrhagic telangiectasia (HHT), also known as Osler-Weber-Rendu syndrome, often manifests with epistaxis.
Does Total Intravenous Anesthesia Provide Significant Blood Loss Reduction During ESS?
Patients with T1 and T2N0 oral tongue cancer are likely to benefit a from specimen-driven margin assessment
- « Previous Page
- 1
- …
- 5
- 6
- 7
- 8
- 9
- …
- 21
- Next Page »